Meanwhile, FNDC5 overexpression in early life significantly reduced the numbers of SA β‐gal‐positive cells and alleviated cardiac hypertrophy and fibrosis in aging hearts (Figure S11E‐H). This evidence concerns the gene FNDC5 and cardiac hypertrophy.